Lee:Literature Proteasomes

From OpenWetWare

Revision as of 12:14, 19 January 2011 by Wooin Lee (Talk | contribs)
Jump to: navigation, search

Home        Research        Lab Members        Publications        JC        Transporters        PK/PD/PGx        Proteasomes        Links        Internal        Contact       

Feel free to add articles ...


Proteasome Biology general review

  1. Hoeller D, Dikic I. Targeting the ubiquitin system in cancer therapy.Nature. 2009 Mar 26;458(7237):438-44. (pmid=19325623)
  2. Mani A, Gelmann EP. The ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol. 2005 Jul 20;23(21):4776-89. (pmid=16034054)
  3. Murata S, Yashiroda H, Tanaka K. Molecular mechanisms of proteasome assembly. Nat Rev Mol Cell Biol. 2009 Feb;10(2):104-15. (pmid=19165213)


  1. Fitzpatrick LR, Small JS, Poritz LS, McKenna KJ, and Koltun WA. . pmid:17160513. PubMed HubMed [1]
  2. Gavilán MP, Castaño A, Torres M, Portavella M, Caballero C, Jiménez S, García-Martínez A, Parrado J, Vitorica J, and Ruano D. . pmid:19012754. PubMed HubMed [2]
  3. Kuhn DJ, Hunsucker SA, Chen Q, Voorhees PM, Orlowski M, and Orlowski RZ. . pmid:19050304. PubMed HubMed [3]
  4. Ho YK, Bargagna-Mohan P, Wehenkel M, Mohan R, and Kim KB. . pmid:17462577. PubMed HubMed [4]
  5. Heink S, Fricke B, Ludwig D, Kloetzel PM, and Krüger E. . pmid:16423992. PubMed HubMed [5]
  6. Namiki S, Nakamura T, Oshima S, Yamazaki M, Sekine Y, Tsuchiya K, Okamoto R, Kanai T, and Watanabe M. . pmid:15907481. PubMed HubMed [6]
  7. Mishto M, Bellavista E, Santoro A, Stolzing A, Ligorio C, Nacmias B, Spazzafumo L, Chiappelli M, Licastro F, Sorbi S, Pession A, Ohm T, Grune T, and Franceschi C. . pmid:16298241. PubMed HubMed [7]
  8. Mishto M, Luciani F, Holzhütter HG, Bellavista E, Santoro A, Textoris-Taube K, Franceschi C, Kloetzel PM, and Zaikin A. . pmid:18336834. PubMed HubMed [8]
  9. Mishto M, Bonafè M, Salvioli S, Olivieri F, and Franceschi C. . pmid:11772516. PubMed HubMed [9]
  10. Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, Störkel S, and Seliger B. . pmid:14750179. PubMed HubMed [10]
  11. Visekruna A, Joeris T, Schmidt N, Lawrenz M, Ritz JP, Buhr HJ, and Steinhoff U. . pmid:19067411. PubMed HubMed [11]
  12. Tu L, Moriya C, Imai T, Ishida H, Tetsutani K, Duan X, Murata S, Tanaka K, Shimokawa C, Hisaeda H, and Himeno K. . pmid:19830724. PubMed HubMed [12]
  13. Vasuri F, Capizzi E, Bellavista E, Mishto M, Santoro A, Fiorentino M, Capri M, Cescon M, Grazi GL, Grigioni WF, D'Errico-Grigioni A, and Franceschi C. . pmid:20510670. PubMed HubMed [13]
All Medline abstracts: PubMed HubMed


  1. pmid=9419215
  2. pmid=12456675 (C-terminal Myc and FLAG tags for MECL, LMP2,Delta, Z)
  3. pmid=10329130 (modification of prepeptide sequence)
  4. pmid=10363659
  5. pmid=9321388 (GFP fusion)
  6. pmid=18728217
  7. pmid=19525961

Resistance mechanisms for proteasome inhibitors

  1. Giada Bianchi,Laura Oliva,Paolo Cascio,5 Niccolo Pengo,Francesca Fontana, Fulvia Cerruti, Andrea Orsi,Elena Pasqualetto, Alexandre Mezghrani, Valeria Calbi, Giovanni Palladini, Nicola Giuliani, Kenneth C. Anderson,Roberto Sitia,and Simone Cenci. The proteasome load versus capacity balance determines apoptotic sensitivity of multiple myeloma cells to proteasome inhibition. Blood. 2009 Mar 26;113(13):3040-9 : 3040-3049.(pmid=19164601)
  2. Lü S, Yang J, Song X, Gong S, Zhou H, Guo L, Song N, Bao X, Chen P, Wang J. Point mutation of the proteasome beta5 subunit gene is an important mechanism of bortezomib resistance in bortezomib-selected variants of Jurkat T cell lymphoblastic lymphoma/leukemia line. J Pharmacol Exp Ther. 2008 Aug;326(2):423-31. (pmid=18502982)
  3. Fuchs D, Berges C, Opelz G, Daniel V, Naujokat C. Increased expression and altered subunit composition of proteasomes induced by continuous proteasome inhibition establish apoptosis resistance and hyperproliferation of Burkitt lymphoma cells. J Cell Biochem. 2008 Jan 1;103(1):270-83. (pmid=17516511)

Proteasome inhibitors in lung cancer

  1. Davies AM, Chansky K, Lara PN Jr, Gumerlock PH, Crowley J, Albain KS, Vogel SJ, Gandara DR; Southwest Oncology Group. Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339). J Thorac Oncol. 2009 Jan;4(1):87-92.

Proteasome inhibitors in pancreatic cancer


  1. 1 pmid=16889756
  2. 2 pmid=16724054
  3. 3 pmid=17183360
  4. 4 pmid=16618413

MDR1 & apoptosis, NF-kB

  1. Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N, Gielen J, Merville MP, and Bours V. . pmid:12527911. PubMed HubMed [1]
  2. Pallis M and Russell N. . pmid:10779437. PubMed HubMed [2]
  3. Smyth MJ, Krasovskis E, Sutton VR, and Johnstone RW. . pmid:9618532. PubMed HubMed [3]
  4. Johnstone RW, Cretney E, and Smyth MJ. . pmid:9920858. PubMed HubMed [4]
  5. Patel VA, Dunn MJ, and Sorokin A. . pmid:12138126. PubMed HubMed [5]
All Medline abstracts: PubMed HubMed
Personal tools